summary
Introduced
05/12/2025
05/12/2025
In Committee
05/12/2025
05/12/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for authority to control.
AI Summary
This bill amends the Controlled Substance, Drug, Device and Cosmetic Act to create a new provision for how psilocybin, a psychoactive compound found in certain mushrooms, will be scheduled and regulated in Pennsylvania. Specifically, the bill requires that whenever the U.S. Food and Drug Administration (FDA) approves a pharmaceutical composition of crystalline polymorph psilocybin, the substance will be automatically scheduled in Pennsylvania to align with federal law. If the U.S. Drug Enforcement Administration (DEA) reschedules this specific form of psilocybin, the Pennsylvania Secretary of Health must notify the Legislative Reference Bureau within five business days, which will then publish the change in the Pennsylvania Bulletin. The rescheduling will take effect thirty days after publication, ensuring that Pennsylvania's drug scheduling remains consistent with federal regulations. This approach provides a streamlined, automatic mechanism for updating the legal status of this specific pharmaceutical form of psilocybin without requiring separate legislative action each time federal scheduling changes.
Committee Categories
Health and Social Services
Sponsors (19)
Jenn O'Mara (D)*,
Lisa Borowski (D),
Danilo Burgos (D),
Missy Cerrato (D),
Mark Gillen (R),
José Giral (D),
Carol Hill-Evans (D),
Joe Hohenstein (D),
Lee James (R),
Tarik Khan (D),
Maureen Madden (D),
Chris Rabb (D),
Nikki Rivera (D),
Ben Sanchez (D),
Mike Schlossberg (D),
Mandy Steele (D),
Michael Stender (R),
Paul Takac (D),
Craig Williams (R),
Last Action
Referred to Health (on 05/12/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...